Author:
Kaylegian Jaeson,Drossos Tina,Hunter Scott J.
Publisher
Springer International Publishing
Reference20 articles.
1. Canter, G. J., de La Torre, R., & Mier, M. (1961). A method for evaluating disability in patients with Parkinson’s disease. Journal of Nervous and Mental Disease, 133, 143–147.
2. Dowding, C. H., Shenton, C. L., & Salek, S. S. (2006). A review of the health-related quality of life and economic impact of Parkinson’s disease. Drugs & Aging, 23(9), 693–721.
3. Dunnett, S. B., Kendall, A. L., Watts, C., & Torres, E. M. (1997). Neuronal cell transplantation for Parkinson’s and Huntington’s diseases. British Medical Journal, 53(4), 757–776.
4. Duvoisin, R. C. (1971). The evaluation of extrapyramidal disease. In J. de Ajuriaguerra & G. Gauthier (Eds.), Monoamines noyaux gris centraux et syndrome de Parkinson (pp. 313–325). Geneve: George & Cie.
5. Forman, M. S., Trojanowski, J. Q., & Lee, V. M.-Y. (2004). Neurodegenerative diseases: A decade of discoveries paves the way for therapeutic breakthroughs. Nature Medicine, 10(10), 1055–1063.